Vanda Pharmaceuticals Inc. SEC filings VNDA

Vanda Pharmaceuticals Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 10, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.

Vanda Pharmaceuticals Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 9, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 19, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
3 Initial insider ownership Jun 8, 2026 Jun 4, 2026
S-8 Employee stock plan registration Jun 5, 2026 —
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 4, 2026
4 Insider transaction May 20, 2026 May 18, 2026
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
EFFECT Filing May 5, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 29, 2026 —
CORRESP Letter to the SEC Apr 24, 2026 —
4 Insider transaction Apr 24, 2026 Apr 22, 2026
3 Initial insider ownership Apr 24, 2026 Apr 22, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 4, 2026
8-K Current report
Officer or director change
Apr 22, 2026 Apr 22, 2026
3 Initial insider ownership Apr 13, 2026 Apr 1, 2026
3 Initial insider ownership Apr 13, 2026 Apr 1, 2026
8-K Current report
Officer or director change
Apr 2, 2026 Mar 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Regulation FD disclosure
Mar 10, 2026 Mar 10, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 24, 2026 Feb 23, 2026
144 Notice of proposed sale Feb 23, 2026 —
8-K Current report
Other events
Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
8-K Current report
Officer or director change
Feb 19, 2026 Feb 18, 2026
UPLOAD Letter from the SEC Feb 18, 2026 —
S-3 Shelf registration Feb 12, 2026 —
10-K Annual report Feb 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 11, 2026 Feb 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 9, 2026 —
8-K Current report
Other events
Jan 8, 2026 Jan 7, 2026
8-K Current report
Other events
Dec 31, 2025 Dec 30, 2025
8-K Current report
Other events
Dec 4, 2025 Dec 4, 2025
8-K Current report
Other events
Nov 28, 2025 Nov 28, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Oct 1, 2025 Oct 1, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 1, 2025 —
4 Insider transaction Jun 16, 2025 Jun 13, 2025
144 Notice of proposed sale Jun 13, 2025 —
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
S-8 Employee stock plan registration Jun 5, 2025 —
8-K Current report
Shareholder vote results
Jun 5, 2025 Jun 5, 2025
DEFA14A Additional proxy material May 27, 2025 —
4 Insider transaction May 21, 2025 May 21, 2025
4 Insider transaction May 19, 2025 May 16, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 15, 2025 —
8-K Current report
Regulation FD disclosure
Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 6, 2025 Mar 6, 2025
4 Insider transaction Mar 5, 2025 Mar 5, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Feb 28, 2025 Feb 28, 2025
4 Insider transaction Feb 27, 2025 Feb 27, 2025
4 Insider transaction Feb 26, 2025 Feb 26, 2025
4 Insider transaction Feb 25, 2025 Feb 25, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
8-K Current report
Officer or director change
Feb 20, 2025 Feb 18, 2025
10-K Annual report Feb 14, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
8-K Current report
Regulation FD disclosure
Jan 27, 2025 Jan 25, 2025
4 Insider transaction Nov 18, 2024 Nov 14, 2024
144 Notice of proposed sale Nov 14, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Other events
Oct 15, 2024 Oct 14, 2024
8-K Current report
Bylaw or fiscal year change
Oct 3, 2024 Oct 2, 2024
8-K Current report
Other events
Sep 19, 2024 Sep 19, 2024
8-A12B/A Filing Aug 8, 2024 —
8-K Current report
Material agreement, Change to shareholder rights
Aug 8, 2024 Aug 7, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
4 Insider transaction Jul 29, 2024 Jul 29, 2024
144 Notice of proposed sale Jul 29, 2024 —
8-K Current report
Other events
Jun 20, 2024 Jun 19, 2024
8-K Current report
Other events
Jun 13, 2024 Jun 13, 2024
8-K Current report
Regulation FD disclosure
Jun 6, 2024 Jun 6, 2024
8-K Current report
Other events
May 24, 2024 May 24, 2024
4 Insider transaction May 24, 2024 May 22, 2024
8-K/A Amended current report
Shareholder vote results
May 24, 2024 May 17, 2024
4 Insider transaction May 21, 2024 May 17, 2024
4 Insider transaction May 21, 2024 May 17, 2024
4 Insider transaction May 21, 2024 May 17, 2024
4 Insider transaction May 21, 2024 May 17, 2024
S-8 Employee stock plan registration May 21, 2024 —
8-K Current report
Shareholder vote results
May 20, 2024 May 17, 2024
DEFA14A Additional proxy material May 13, 2024 —
DEFA14A Additional proxy material May 9, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
8-K Current report
Other events
May 7, 2024 May 7, 2024
8-A12B/A Filing May 3, 2024 —
8-K Current report
Material agreement, Change to shareholder rights
May 3, 2024 May 3, 2024
ARS/A Amendment to annual report Apr 29, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 May 17, 2024
8-A12B Filing Apr 17, 2024 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 17, 2024 Apr 17, 2024
8-K Current report
Other events
Apr 3, 2024 Apr 2, 2024
8-K Current report
Other events
Mar 7, 2024 Mar 6, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
144 Notice of proposed sale Mar 4, 2024 —
144 Notice of proposed sale Mar 4, 2024 —
144 Notice of proposed sale Mar 4, 2024 —
144 Notice of proposed sale Mar 4, 2024 —
144 Notice of proposed sale Mar 4, 2024 —
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
8-K Current report
Officer or director change
Feb 21, 2024 Feb 16, 2024
8-K/A Amended current report Feb 16, 2024 Dec 7, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
10-K Annual report Feb 8, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 7, 2024 Feb 7, 2024
8-K Current report
Other events
Feb 5, 2024 Feb 5, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 22, 2024 —
8-K Current report
Bylaw or fiscal year change
Dec 15, 2023 Dec 13, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Dec 7, 2023 Dec 7, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
SC 13G/A Amended ownership over 5% (passive) Oct 6, 2023 —
4 Insider transaction Aug 23, 2023 Aug 21, 2023
8-K Current report
Other events
Aug 21, 2023 Aug 16, 2023
144 Notice of proposed sale Aug 21, 2023 —
4 Insider transaction Aug 11, 2023 Aug 10, 2023
144 Notice of proposed sale Aug 10, 2023 —
4 Insider transaction Aug 1, 2023 Jul 28, 2023
144 Notice of proposed sale Jul 28, 2023 —
10-Q Quarterly report Jul 28, 2023 Jun 30, 2023
8-K Current report
Results of operations
Jul 27, 2023 Jul 27, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
144 Notice of proposed sale Jun 15, 2023 —
4 Insider transaction Jun 15, 2023 Jun 13, 2023
144 Notice of proposed sale Jun 13, 2023 —
4 Insider transaction Jun 12, 2023 Jun 8, 2023
4 Insider transaction Jun 12, 2023 Jun 8, 2023
4 Insider transaction Jun 12, 2023 Jun 8, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VNDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Washington, DC
SEC filer status
Accelerated filer
SEC CIK
1347178

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.